Seminars in Hematology
Volume 45, Issue 1 , Pages 3-7, January 2008

World Health Organization and International Prognostic Scoring System: The Limitations of Current Classification Systems in Assessing Prognosis and Determining Appropriate Therapy in Myelodysplastic Syndromes

  • Charles A. Schiffer

      Affiliations

    • Corresponding Author InformationAddress correspondence to Charles A. Schiffer, MD, Division of Hematology/Oncology, Karmanos Cancer Institute, HWCRB-4th Floor, 4100 John R, Wayne State University School of Medicine, Detroit, MI 48201.

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(07)00153-9

doi:10.1053/j.seminhematol.2007.10.002

Seminars in Hematology
Volume 45, Issue 1 , Pages 3-7, January 2008

Article Tools